Cytomel

What is Cytomel?

Cytomel is the brand name for liothyronine, a synthetic version of the active thyroid hormone triiodothyronine (T3). The active ingredient is identical to generic Liothyronine; the difference is the manufacturer, the tablet, and sometimes the inactive fillers. Cytomel is most often prescribed for Hypothyroidism in patients who continue to have symptoms on levothyroxine (T4) alone, and occasionally as part of a regimen after thyroidectomy or Radioactive Iodine Ablation.

Unlike T4 — which the body has to convert before it becomes useful — Cytomel is already in active form, so it works faster, more potently, and for a shorter duration than T4.

How does Cytomel work?

Once absorbed, T3 from Cytomel travels to cells throughout the body and binds directly to thyroid hormone receptors inside the nucleus. Those receptors then activate the genes that govern metabolism, body temperature, heart rate, cognition, mood, and menstrual cycles. Because T3 has a short half-life of roughly 24 hours and a sharp peak shortly after dosing, Cytomel is often divided into morning and early-afternoon doses, or replaced with a compounded slow-release T3 for a smoother curve.

Monitoring includes TSH, Free T4, and Free T3. TSH alone is not enough — T3 medication suppresses TSH more strongly than T4 does, so an isolated low TSH is not automatically a sign of over-replacement.

When is it prescribed?

Cytomel is typically considered for:

• Patients on levothyroxine who still feel hypothyroid despite an in-range TSH.
• Documented poor T4-to-T3 conversion (low Free T3, elevated reverse T3).
• Post-thyroidectomy or post-RAI patients who have lost the gland's natural T3 production.
• Some patients alongside Natural Desiccated Thyroid for fine-tuning.

Patient considerations

Side effects almost always reflect too much T3 — palpitations, jitteriness, anxiety, insomnia, tremor, sweating, headaches, and unintended weight loss. Long-term over-replacement can accelerate bone loss and increase the risk of atrial fibrillation, particularly in older women. Cytomel is not appropriate for people with untreated adrenal insufficiency, uncorrected hyperthyroidism, or unstable cardiac conditions, and it must be introduced cautiously in anyone with heart disease.

Cytomel also costs more than generic liothyronine and is sometimes harder to find at standard doses. Many patients do well on the generic; others feel a clear difference between brands.

At Modern Thyroid Clinic, we frequently add a small, carefully monitored amount of T3 — Cytomel, generic liothyronine, or a Compounded T3 T4 preparation — to women who have been told their thyroid is "normal" but still feel exhausted on T4 alone.